German institute says coronavirus vaccinations could start in early 2021 | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
The Business Standard

Monday
October 02, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
MONDAY, OCTOBER 02, 2023
German institute says coronavirus vaccinations could start in early 2021

Coronavirus chronicle

Reuters
19 August, 2020, 11:50 am
Last modified: 19 August, 2020, 11:54 am

Related News

  • Moderna ties up with Immatics to boost cancer vaccine development
  • The next big advance in cancer treatment could be a vaccine
  • MoU signed with US company to set up first ever vaccine producing plant in country
  • Positive results for potential first chikungunya vaccine
  • G7 plans new vaccine effort for developing nations, Yomiuri reports

German institute says coronavirus vaccinations could start in early 2021

The coronavirus has infected more than 22 million people worldwide since first being detected in China late last year. Almost 800,000 have died

Reuters
19 August, 2020, 11:50 am
Last modified: 19 August, 2020, 11:54 am
Photo provided by Russian Direct Investment Fund (RDIF) shows a researcher working in a laboratory of the Gamaleya Scientific Research Institute of Epidemiology and Microbiology in Moscow, Russia.Photo:Xinhua via UNB
Photo provided by Russian Direct Investment Fund (RDIF) shows a researcher working in a laboratory of the Gamaleya Scientific Research Institute of Epidemiology and Microbiology in Moscow, Russia.Photo:Xinhua via UNB

The head of Germany's vaccines regulator said some groups of people living in Germany could be vaccinated early next year against the coronavirus that has killed hundreds of thousands and wreaked havoc on the global economy.

More than half a dozen drugmakers around the world are conducting advanced clinical trials, each with tens of thousands of participants, and several expect to know if their Covid-19 vaccines work and are safe by the end of this year.

Klaus Cichutek, head of the Paul Ehrlich Institut, told the Funke group of newspapers that data from Phase I and Phase II trials showed some vaccines triggered an immune response against the coronavirus.

"If data from Phase III trials shows the vaccines are effective and safe, the first vaccines could be approved at the beginning of the year, possibly with conditions attached," he said.

"Based on assurances from manufacturers, the first doses for people in Germany will be available at that time, in accordance with the priorities set by the Standing Committee on Vaccination," Cichutek said, referring to the group that makes recommendations for the use of licensed vaccines in Germany.

The coronavirus has infected more than 22 million people worldwide since first being detected in China late last year. Almost 800,000 have died.

Several companies, including Moderna, AstraZeneca, and Pfizer Inc, say they each expect to make more than 1 billion doses of a vaccine next year.

German biotechnology firm CureVac has not ruled out a speedy approval process for its prospective vaccine and expects to have it on the market by mid-2021.

Last week, Russian President Vladimir Putin said Russia had become the first country to grant regulatory approval to a Covid-19 vaccine after less than two months of human testing. Russia has said the vaccine will be rolled out by the end of this month.

German company / Vaccine / 2021

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Big drops in remittance, exports make reserves struggle harsher
    Big drops in remittance, exports make reserves struggle harsher
  • Representational image. Photo: Collected
    Why Bangladesh’s reserves tumble, Sri Lanka’s improve
  • Sketch: TBS
    Stop financing budget deficit by printing money to check inflation, Sadiq Ahmed tells BB

MOST VIEWED

  • Paperfly aborts flight
    Paperfly aborts flight
  • Photo: TBS
    Habibur Rahman takes charge as 36th DMP commissioner
  • Some banks get more remittance. Is it for extra efforts, or higher dollar rates?
    Some banks get more remittance. Is it for extra efforts, or higher dollar rates?
  • How China's Belt and Road changing Bangladesh's  infrastructures
    How China's Belt and Road changing Bangladesh's infrastructures
  • Photo: TBS
    Dhaka traffic slowest in world: Study
  • US dollar banknotes are seen in this illustration taken on 10 March 2023. Photo: Reuters
    Remittance earnings in September lowest in 41 months

Related News

  • Moderna ties up with Immatics to boost cancer vaccine development
  • The next big advance in cancer treatment could be a vaccine
  • MoU signed with US company to set up first ever vaccine producing plant in country
  • Positive results for potential first chikungunya vaccine
  • G7 plans new vaccine effort for developing nations, Yomiuri reports

Features

Illustration: Collected

Apology to a life forgotten to live

9h | Features
Photo: Kazi Ashraf Uddin

Coffee: More than a beverage, something of a beloved

12h | Features
The price back to the normal range is possible if the corporations who control the feed market reduce the feed and chick prices. Photo: Noor-A-Alam

Will eggs ever return to their 'normal' price?

14h | Features
Photo & Coffee Sketch: Touseful Isalm

A coffee conversation with Rumi

1d | Features

More Videos from TBS

Everything about the ICC Cricket World Cup 2023 stadiums: Part 1

Everything about the ICC Cricket World Cup 2023 stadiums: Part 1

6h | TBS SPORTS
Apple is bringing new software updates to prevent overheating

Apple is bringing new software updates to prevent overheating

8h | Tech Talk
A unique study cafe in the city

A unique study cafe in the city

7h | TBS Stories
Reserves are falling even as the dollar's share of global payments rises

Reserves are falling even as the dollar's share of global payments rises

11h | TBS Economy
EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]